BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37384269)

  • 1. Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm.
    Hwang S; Kim KH; Moon DB; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
    J Liver Cancer; 2021 Mar; 21(1):45-57. PubMed ID: 37384269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
    Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.
    Hwang S; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Lee SG
    J Gastrointest Surg; 2016 Nov; 20(11):1807-1820. PubMed ID: 27311982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.
    Hwang S; Joh JW; Wang HJ; Kim DG; Kim KS; Suh KS; Kim SH; Yu HC; Cho CK; Lee YJ; Kim KH; Kim JM; Kim BW; Lee SG
    World J Surg; 2018 Aug; 42(8):2579-2591. PubMed ID: 29340726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
    Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
    Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the OncoHepa test, a multigene expression profile test, and the tumor marker-volume score to predict postresection outcome in small solitary hepatocellular carcinomas.
    Ha SM; Hwang S; Park JY; Lee YJ; Kim KH; Song GW; Jung DH; Yu YS; Kim J; Lee KJ; Tak E; Park YH; Lee SG
    Ann Surg Treat Res; 2018 Dec; 95(6):303-311. PubMed ID: 30505821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
    Hwang S; Moon DB; Kim KH; Ahn CS; Song GW; Jung DH; Park GC; Lee SG
    J Gastrointest Surg; 2021 Jul; 25(7):1745-1759. PubMed ID: 32948961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Prediction of Posttransplant Hepatocellular Carcinoma Prognosis Using ADV Score: Validation with Korea-Nationwide Transplantation Registry Database.
    Park GC; Hwang S; You YK; Choi Y; Kim JM; Joo DJ; Ryu JH; Choi D; Kim BW; Kim DS; Nah YW; Kang KJ; Cho JY; Yu HC; Kim DG
    J Gastrointest Surg; 2023 Jul; 27(7):1353-1366. PubMed ID: 37039979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: Quantitative prediction using ADV score.
    Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Yoon YI; Lee SG
    J Hepatobiliary Pancreat Sci; 2021 Nov; 28(11):1000-1013. PubMed ID: 33175453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma-a multicenter propensity score matching analysis.
    Xu XF; Wu H; Li JD; Yao LQ; Huang B; Diao YK; Chen TH; Gu WM; Chen Z; Li J; Zhang YM; Wang H; Liang YJ; Zhou YH; Li C; Wang MD; Zhang CW; Pawlik TM; Lau WY; Shen F; Yang T
    Hepatobiliary Surg Nutr; 2023 Jun; 12(3):314-327. PubMed ID: 37351131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.
    Zhao H; Hua Y; Lu Z; Gu S; Zhu L; Ji Y; Qiu Y; Dai T; Jin H
    Oncotarget; 2017 Sep; 8(37):61203-61214. PubMed ID: 28977857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database.
    Park GC; Hwang S; Park YH; Choi JU;
    Ann Surg Treat Res; 2020 May; 98(5):235-246. PubMed ID: 32411628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy.
    Wei B; Chen JS; Yang SL; Chen GG; He H
    Transl Cancer Res; 2019 Aug; 8(4):1438-1448. PubMed ID: 35116886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion.
    Lu L; Wei W; Huang C; Li S; Zhong C; Wang J; Yu W; Zhang Y; Chen M; Ling Y; Guo R
    Hepatol Int; 2021 Jun; 15(3):651-662. PubMed ID: 33835379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.
    Zhou Q; Zhou C; Yin Y; Chen W; Liu C; Atyah M; Weng J; Shen Y; Yi Y; Ren N
    Ann Transl Med; 2021 Mar; 9(5):402. PubMed ID: 33842623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of gadoxetic acid-enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma.
    Kim SS; Lee S; Kim MJ
    Eur Radiol; 2021 May; 31(5):3405-3416. PubMed ID: 33146795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.